Indication

Insulin Sensitivity/Resistance

1 clinical trial

1 product

Clinical trial

Endoscopic Sleeve Gastroplasty (ESG) Versus Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) Versus ESG + GLP-1RA in Patients With Obesity, Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis: A Randomized Controlled Trial

Status: Not yet recruiting, Estimated PCD: 2025-07-01

Product